Dow Jones received a payment from EQS/DGAP to publish this press release.
EQS-News / 10/10/2017 / 07:00 UTC+8
*[For Immediate Release]*
/
*Union Medical Healthcare's sales contracts surged by 45%
in the First Half of FY2017/18*
(9 October 2017, Hong Kong) *Union Medical Healthcare Limited* ("Union
Medical Healthcare" or the "Company"; together with its subsidiaries, the
"Group", SEHK stock code: 2138), a leading medical aesthetic service
provider in Hong Kong, announced that based on the latest assessment by the
Board with reference to the preliminary unaudited consolidated management
accounts of the Group currently available, the Group expects to record an
increase of no less than 45% in total sales contracts for the six months
ended 30 September 2017 as compared with the same period last year, which
was mainly attributable to the Group's elevated quality of medical services
and its expansion of service mix, leading to an increase in customer
spending, in particular those of PRC customers.
*Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of
Union Medical Healthcare *said, "Union Medical Healthcare has always been
committed to establishing the highest standard in the industry. Whilst
aggressive diversification of services scope was achieved by introducing
segments such as dental services, comprehensive health screening and
chiropractic services, the Group's cross-selling capabilities has been
proven from the synergistic effect that was being created. Our outstanding
sales performance is a testament to our insightful operative strategies of
offering one-stop medical, health and beauty services. We will continue to
enhance our product mix and actively capture opportunities for market
consolidation to enlarge our market share, as to strengthen the Group's
leading position in the market for aesthetic medical services to generate
better returns for our investors."
_- End -_
*About Union Medical Healthcare Limited*
Union Medical Healthcare is principally engaged in the provision of one-stop
aesthetic medical, beauty and health management solutions with 46 clinics
and servicing centres across Hong Kong, the PRC and Macao as at 30 September
2017. In 2016, the Group obtained the Hong Kong Top Service Brand and opened
re:HEALTH, a one-stop health management centre, to provide a full range of
services and products, including comprehensive health screening, health
product and health management services. The Group is the largest aesthetic
medical service provider in Hong Kong in terms of revenue. The Group ranked
first in Hong Kong from 2012 to 2016 in terms of the number of aesthetic
injection procedures performed involving utilization of the top-six
revenue-generating aesthetic medications in Hong Kong; and was the Black
Diamond Provider of the transparent orthodontic device for teeth alignment,
Invisalign(R), in 2015 and 2016. The Group has successfully built DR REBORN,
a well-recognized brand in Hong Kong, with the reputation of being a premier
provider of aesthetic medical services in Hong Kong.
*For further information, please contact:
iPR Ogilvy & Mather*
Callis Lau / Molisa Lau / Maggie Chui / Francesca Yeung
Tel: (852) 2136 6952 / 2136 6953 / 2136 8059 / 3920 7639
Fax: (852) 3170 6606
Email: umh@iprogilvy.com
10/10/2017 Dissemination of a Marketing Press Release, transmitted by EQS
Group.
The issuer is solely responsible for the content of this announcement.
Media archive at www.todayir.com
(END) Dow Jones Newswires
October 09, 2017 19:00 ET (23:00 GMT)
